Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IDIOPATHIC PARKINSON'S DISEASE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00400634
What this trial is testing

Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Sangamo Therapeutics 58
Large-scale testing (Phase 3)Ended earlyNCT03051607
What this trial is testing

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

Who this might be right for
Idiopathic Parkinson Disease
Biotie Therapies Inc. 66
Not applicableStudy completedNCT03944785
What this trial is testing

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

Who this might be right for
Idiopathic Parkinson Disease
Supernus Pharmaceuticals, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT01617135
What this trial is testing

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 25
Testing effectiveness (Phase 2)Looking for participantsNCT06680830
What this trial is testing

Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonIdiopathic Parkinson Disease+2 more
Neuron23 Inc. 150
Early research (Phase 1)Looking for participantsNCT07840027
What this trial is testing

Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)Idiopathic Parkinson's Disease
Tridem Bioscience FlexCo 36
Not applicableUnknownNCT05353855
What this trial is testing

Neural Correlates of Impulsivity in Idiopathic REM Sleep Behavior Disorder

Who this might be right for
Parkinson Disease
Chinese University of Hong Kong 96
Not applicableStudy completedNCT05862649
What this trial is testing

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

Who this might be right for
Parkinson Disease
NeuraLight 300
Testing effectiveness (Phase 2)Study completedNCT00160576
What this trial is testing

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Who this might be right for
Idiopathic Parkinson Disease
UCB Pharma 30
Not applicableStudy completedNCT01246336
What this trial is testing

Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath

Who this might be right for
Parkinson's DiseaseParkinsonism
Rambam Health Care Campus 41
Large-scale testing (Phase 3)Study completedNCT01227655
What this trial is testing

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 427
Testing effectiveness (Phase 2)Study completedNCT05931575
What this trial is testing

Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson´s Disease
Technical University of Munich 81
Testing effectiveness (Phase 2)Study completedNCT01026428
What this trial is testing

Assess the Effect of Safinamide on Levodopa Pharmacokinetics

Who this might be right for
Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA 24
Testing effectiveness (Phase 2)Study completedNCT01683292
What this trial is testing

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
South Glasgow University Hospitals NHS Trust 29
Large-scale testing (Phase 3)Study completedNCT00642889
What this trial is testing

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 227
Very early researchStudy completedNCT02879136
What this trial is testing

TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease

Who this might be right for
Parkinson's Disease, Idiopathic
Hubert Fernandez 23
Not applicableStudy completedNCT03665493
What this trial is testing

Dopamine Effect on Inhibitory Control

Who this might be right for
Idiopathic Parkinson's Disease
Giovanni Mirabella 90
Large-scale testing (Phase 3)Study completedNCT03881371
What this trial is testing

Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa

Who this might be right for
Parkinson Disease
Zambon SpA 307
Post-approval studies (Phase 4)UnknownNCT06115538
What this trial is testing

Comparison of Dopamin Level in Idiopathic Parkinson's Patients

Who this might be right for
Parkinson DiseaseTreatment Adherence
Ankara Ataturk Sanatorium Training and Research Hospital 96
Large-scale testing (Phase 3)Study completedNCT05357989
What this trial is testing

Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Who this might be right for
Parkinson's Disease, Idiopathic
Annovis Bio Inc. 523
Next Page